YA-101 for multiple system atrophy

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Feb 2025: Trial registered, NCT06848231
  2. 3 Mar 2025: Trial started, NCT06848231

The trials

NCT06848231: A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy

State
Under way
Phase
Phase 2
People
75 planned
Started
3 Mar 2025
Primary completion
30 Jun 2027
Arms
YA-101
Results
None posted
  1. 26 Feb 2025: Trial registered
  2. 3 Mar 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.